Cargando…
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study
An altered gut microbiota is a possible contributing pathogenic factor in myasthenia gravis (MG), an autoimmune neuromuscular disease. However, the significance of the fungal microbiome is an understudied and neglected part of the intestinal microbiome in MG. We performed a sub-analysis of the MYBIO...
Autores principales: | Verhasselt, Hedda Luise, Ramakrishnan, Elakiya, Schlag, Melina, Marchesi, Julian R, Buer, Jan, Kleinschnitz, Christoph, Hagenacker, Tim, Totzeck, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218993/ https://www.ncbi.nlm.nih.gov/pubmed/37233280 http://dx.doi.org/10.3390/jof9050569 |
Ejemplares similares
-
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study
por: Totzeck, Andreas, et al.
Publicado: (2021) -
CIDP, myasthenia gravis, and membranous glomerulonephritis – three autoimmune disorders in one patient: a case report
por: Bolz, Saskia, et al.
Publicado: (2018) -
Understanding the burden of refractory myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2019) -
Exploring the Gut Microbiome in Myasthenia Gravis
por: Thye, Angel Yun-Kuan, et al.
Publicado: (2022) -
Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022)